• CANbridge Pharmaceuticals expands partnership with Wuxi Biologics pharmaceutical-technology
    January 11, 2019
    China’s CANbridge Pharmaceuticals has expanded its alliance with WuXi Biologics for the discovery, development and commercialisation of four additional drug candidates to potentially treat rare genetic chronic diseases.....
PharmaSources Customer Service